SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-014681
Filing Date
2022-05-23
Accepted
2022-05-23 06:20:59
Documents
73
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1608464
2 ex31-1.htm EX-31.1 20134
3 ex31-2.htm EX-31.2 22182
4 ex32-1.htm EX-32.1 6740
5 ex32-2.htm EX-32.2 6893
  Complete submission text file 0001493152-22-014681.txt   8565892

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT otlc-20220331.xsd EX-101.SCH 60644
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT otlc-20220331_cal.xml EX-101.CAL 47608
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT otlc-20220331_def.xml EX-101.DEF 343527
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT otlc-20220331_lab.xml EX-101.LAB 475434
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT otlc-20220331_pre.xml EX-101.PRE 420172
67 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1556969
Mailing Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301
Business Address 29397 AGOURA RD. #107 AGUORA HILLS CA 91301 650-635-7000
Oncotelic Therapeutics, Inc. (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 22949541
SIC: 2834 Pharmaceutical Preparations